News

March 9, 2018

Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology
INDIANAPOLIS, March 9, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Maura Dickler, M.D., a prestigious breast cancer researcher, will join Lilly Oncology as Vice President of Late Phase Development on May 7, 2018.  Dr. Dickler is currently the Section Head, Endocrine Therapy Clinical Research Program at Memori...

Showing 1-1 of 1 Page: 1